Catalent
CTLT
#1736
Rank
NZ$19.93 B
Marketcap
NZ$109.80
Share price
0.00%
Change (1 day)
15.31%
Change (1 year)
Catalent is an American pharmaceutical contract research and development company.

Market capitalization of Catalent (CTLT)

Last known market cap: NZ$19.93 Billion

On February 19, 2025 Catalent had a market cap of NZ$19.93 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Catalent from 2014 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$19.93 B-2.45%
2024NZ$20.43 B59.19%
2023NZ$12.83 B0.59%
2022NZ$12.75 B-61.97%
2021NZ$33.55 B41.24%
2020NZ$23.75 B94.1%
2019NZ$12.23 B80.8%
2018NZ$6.76 B-11.92%
2017NZ$7.68 B58.28%
2016NZ$4.85 B6.62%
2015NZ$4.55 B3.37%
2014NZ$4.40 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Supernus Pharmaceuticals
SUPN
NZ$4.50 B-77.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
NZ$1.30 B-93.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
NZ$17.05 B-14.43%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Intercept Pharmaceuticals
ICPT
NZ$1.37 B-93.10%๐Ÿ‡บ๐Ÿ‡ธ USA